Anticardiolipin antibody in lupus erythematosus

M. Marschalko, A. Ruzsovits, A. Horváth

Research output: Contribution to journalArticle

Abstract

Introduction. Anticardiolipin antibodies are associated with vascular thrombotic events in different dermatological, infectious and autoimmune diseases. Methods. In the present study the frequency of IgG anticardiolipin antibody was determined by ELISA in discoid, systemic and subacute lupus erythematosus. IgG anticardiolipin ELISA was made during a 5-year follow-up in 102 sera of 16 patients with SLE and in 32 sera of 5 patients with subacute cutaneous lupus erythematosus. The result of anticardiolipin ELISA test was compared with the ds DNA antibody ELISA result, thrombocyte count, and clinical thrombotic events in patients with systemic lupus erythematosus. Results. Anticardiolipin antibody was shown in 64 out of 231 /27,7%/ patients with systemic, 3 out of 32 patients /9,4%/ with subacute cutaneous and 2 out of 26 patients /7,7%/ with discoid lupus erythematosus. 41 out of 337 control persons /12,2%/ had anticardiolipin antibody. In patients with systemic and subacute cutaneous lupus erythematosus the levels of anticardiolipin antibody were followed during the 5- year follow-up. Conclusion. There was no significant correlation between anticardiolipin and anti-ds DNA antibody determinations, between anticardiolipin ELISA and platelet count and anticardiolipin ELISA and thrombotic clinical events in patients with systemic lupus erythematosus.

Original languageEnglish
Pages (from-to)47-55
Number of pages9
JournalActa Dermatovenerologica Alpina, Panonica et Adriatica
Volume7
Issue number2
Publication statusPublished - 1998

Fingerprint

Anticardiolipin Antibodies
Enzyme-Linked Immunosorbent Assay
Cutaneous Lupus Erythematosus
Systemic Lupus Erythematosus
Immunoglobulin G
Discoid Lupus Erythematosus
Antinuclear Antibodies
DNA
Serum
Platelet Count
Autoimmune Diseases
Communicable Diseases
Blood Vessels
Blood Platelets
Skin
Antibodies

Keywords

  • Anti-ds DNA antibody
  • Antibody
  • Anticardiolipin
  • Antiphospholipid
  • Thrombocytopenia
  • Thrombotic events

ASJC Scopus subject areas

  • Dermatology

Cite this

Anticardiolipin antibody in lupus erythematosus. / Marschalko, M.; Ruzsovits, A.; Horváth, A.

In: Acta Dermatovenerologica Alpina, Panonica et Adriatica, Vol. 7, No. 2, 1998, p. 47-55.

Research output: Contribution to journalArticle

@article{311313c15cb347599454845a4a5acebc,
title = "Anticardiolipin antibody in lupus erythematosus",
abstract = "Introduction. Anticardiolipin antibodies are associated with vascular thrombotic events in different dermatological, infectious and autoimmune diseases. Methods. In the present study the frequency of IgG anticardiolipin antibody was determined by ELISA in discoid, systemic and subacute lupus erythematosus. IgG anticardiolipin ELISA was made during a 5-year follow-up in 102 sera of 16 patients with SLE and in 32 sera of 5 patients with subacute cutaneous lupus erythematosus. The result of anticardiolipin ELISA test was compared with the ds DNA antibody ELISA result, thrombocyte count, and clinical thrombotic events in patients with systemic lupus erythematosus. Results. Anticardiolipin antibody was shown in 64 out of 231 /27,7{\%}/ patients with systemic, 3 out of 32 patients /9,4{\%}/ with subacute cutaneous and 2 out of 26 patients /7,7{\%}/ with discoid lupus erythematosus. 41 out of 337 control persons /12,2{\%}/ had anticardiolipin antibody. In patients with systemic and subacute cutaneous lupus erythematosus the levels of anticardiolipin antibody were followed during the 5- year follow-up. Conclusion. There was no significant correlation between anticardiolipin and anti-ds DNA antibody determinations, between anticardiolipin ELISA and platelet count and anticardiolipin ELISA and thrombotic clinical events in patients with systemic lupus erythematosus.",
keywords = "Anti-ds DNA antibody, Antibody, Anticardiolipin, Antiphospholipid, Thrombocytopenia, Thrombotic events",
author = "M. Marschalko and A. Ruzsovits and A. Horv{\'a}th",
year = "1998",
language = "English",
volume = "7",
pages = "47--55",
journal = "Acta Dermatovenerologica Alpina, Panonica et Adriatica",
issn = "1318-4458",
publisher = "Slovenian Medical Society",
number = "2",

}

TY - JOUR

T1 - Anticardiolipin antibody in lupus erythematosus

AU - Marschalko, M.

AU - Ruzsovits, A.

AU - Horváth, A.

PY - 1998

Y1 - 1998

N2 - Introduction. Anticardiolipin antibodies are associated with vascular thrombotic events in different dermatological, infectious and autoimmune diseases. Methods. In the present study the frequency of IgG anticardiolipin antibody was determined by ELISA in discoid, systemic and subacute lupus erythematosus. IgG anticardiolipin ELISA was made during a 5-year follow-up in 102 sera of 16 patients with SLE and in 32 sera of 5 patients with subacute cutaneous lupus erythematosus. The result of anticardiolipin ELISA test was compared with the ds DNA antibody ELISA result, thrombocyte count, and clinical thrombotic events in patients with systemic lupus erythematosus. Results. Anticardiolipin antibody was shown in 64 out of 231 /27,7%/ patients with systemic, 3 out of 32 patients /9,4%/ with subacute cutaneous and 2 out of 26 patients /7,7%/ with discoid lupus erythematosus. 41 out of 337 control persons /12,2%/ had anticardiolipin antibody. In patients with systemic and subacute cutaneous lupus erythematosus the levels of anticardiolipin antibody were followed during the 5- year follow-up. Conclusion. There was no significant correlation between anticardiolipin and anti-ds DNA antibody determinations, between anticardiolipin ELISA and platelet count and anticardiolipin ELISA and thrombotic clinical events in patients with systemic lupus erythematosus.

AB - Introduction. Anticardiolipin antibodies are associated with vascular thrombotic events in different dermatological, infectious and autoimmune diseases. Methods. In the present study the frequency of IgG anticardiolipin antibody was determined by ELISA in discoid, systemic and subacute lupus erythematosus. IgG anticardiolipin ELISA was made during a 5-year follow-up in 102 sera of 16 patients with SLE and in 32 sera of 5 patients with subacute cutaneous lupus erythematosus. The result of anticardiolipin ELISA test was compared with the ds DNA antibody ELISA result, thrombocyte count, and clinical thrombotic events in patients with systemic lupus erythematosus. Results. Anticardiolipin antibody was shown in 64 out of 231 /27,7%/ patients with systemic, 3 out of 32 patients /9,4%/ with subacute cutaneous and 2 out of 26 patients /7,7%/ with discoid lupus erythematosus. 41 out of 337 control persons /12,2%/ had anticardiolipin antibody. In patients with systemic and subacute cutaneous lupus erythematosus the levels of anticardiolipin antibody were followed during the 5- year follow-up. Conclusion. There was no significant correlation between anticardiolipin and anti-ds DNA antibody determinations, between anticardiolipin ELISA and platelet count and anticardiolipin ELISA and thrombotic clinical events in patients with systemic lupus erythematosus.

KW - Anti-ds DNA antibody

KW - Antibody

KW - Anticardiolipin

KW - Antiphospholipid

KW - Thrombocytopenia

KW - Thrombotic events

UR - http://www.scopus.com/inward/record.url?scp=0031872703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031872703&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031872703

VL - 7

SP - 47

EP - 55

JO - Acta Dermatovenerologica Alpina, Panonica et Adriatica

JF - Acta Dermatovenerologica Alpina, Panonica et Adriatica

SN - 1318-4458

IS - 2

ER -